Drug Type Biological products |
Synonyms MCC, MCC/HA, MCNA + [6] |
Target |
Action stimulants |
Mechanism IL-12 stimulants(Interleukin-12 stimulants), IL-6 stimulants(Interleukin-6 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bladder Cancer | NDA/BLA | United States | - | |
Carcinoma in Situ | Phase 3 | United States | 01 Nov 2010 | |
Carcinoma in Situ | Phase 3 | Canada | 01 Nov 2010 | |
Carcinoma in Situ | Phase 3 | Germany | 01 Nov 2010 | |
Carcinoma in Situ | Phase 3 | Netherlands | 01 Nov 2010 | |
Carcinoma in Situ | Phase 3 | Poland | 01 Nov 2010 | |
Carcinoma in Situ | Phase 3 | United Kingdom | 01 Nov 2010 | |
Local Neoplasm Recurrence | Phase 3 | United States | 01 Nov 2010 | |
Local Neoplasm Recurrence | Phase 3 | Canada | 01 Nov 2010 | |
Local Neoplasm Recurrence | Phase 3 | Germany | 01 Nov 2010 |
Phase 3 | 84 | (EN3348) | pippvbzyvx = yzvwalhlva uqnblzoumx (awwvkjbrwj, uprtoyimgo - mpattldalb) View more | - | 11 Sep 2014 | ||
(Mitomycin C) | pippvbzyvx = zjaebxkfxw uqnblzoumx (awwvkjbrwj, ldrrybzukr - vcucreedqv) View more |